Vor Biopharma
Dan Goulet has a diverse scientific work experience. Dan worked as a Scientist II at Vor Bio starting from February 2023. Before that, from March 2022 to October 2022, they held the same position at Repertoire Immune Medicines. Prior to their industry experience, they worked as a Postdoctoral Research Associate at the Massachusetts Institute of Technology (MIT) from February 2020 to February 2022, and at the University of North Carolina at Chapel Hill from November 2018 to February 2020. Dan also has experience as a Research Technician at MIT from May 2007 to May 2011.
Dan Goulet pursued their education starting in 2003 at the College of the Holy Cross, where they obtained their Bachelor's Degree in Chemistry in 2009. After that, they went on to the University of North Carolina at Chapel Hill, where they pursued and earned their Doctor of Philosophy (Ph.D.) in Pharmacology from 2011 to 2018.
This person is not in the org chart
Vor Biopharma
3 followers
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.